Oral Contraceptives and the Risk of Cardiovascular Disease

被引：1

作者：

Luo J. ^{[1
]}

Margolis K.L. ^{[2
]}

机构：

[1] Department of Community Medicine, West Virginia University, Morgantown, WV, 26506-9190

[2] HealthPartners Research Foundation, Minneapolis, MN, 55440-1524, PO Box 1524

来源：

Current Cardiovascular Risk Reports | 2010年 / 4卷 / 3期

关键词：

Myocardial infarction; Oral contraceptives; Stroke; Venous thromboembolism;

D O I：

10.1007/s12170-010-0095-7

中图分类号：

学科分类号：

摘要：

Over the years, the estrogen dose in combined oral contraceptives has been progressively reduced to decrease the risk of thrombosis; however, the cardiovascular safety of widely used oral contraceptives is still a concern. Low-dose oral contraceptives, especially those containing certain third-generation progestins, have been found to increase the risk of venous thrombosis. Low-dose oral contraceptive use has not been clearly shown to increase the risk of arterial vascular disease. The risk of arterial and venous thrombosis in young healthy women taking low-dose oral contraceptives is outweighed by the risks of unintended pregnancy. Women with cardiovascular risk factors, particularly smoking, must weigh the risk of thrombotic events against the convenience and efficacy of alternative methods for preventing pregnancy. As oral contraceptives are increasingly used in the later reproductive years, further research is needed to define the risks in older women, for whom the prevalence of risk factors and the incidence of cardiovascular disease are higher. © 2010 Springer Science+Business Media, LLC.

引用

页码：222 / 228

页数：6

共 49 条

[31]

Martinelli I., Battaglioli T., Burgo I., Et al., Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke, Haematologica, 91, pp. 844-847, (2006)

[32]

Pezzini A., Grassi M., Iacoviello L., Et al., Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives, J Neurol Neurosurg Psychiatry, 78, pp. 271-276, (2007)

[33]

Pruissen D.M., Slooter A.J., Rosendaal F.R., Et al., Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke, Blood, 111, pp. 1282-1286, (2008)

[34]

Croft P., Hannaford P., Risk factors for acute myocardial infarction in women, Bmj, 298, (1989)

[35]

Mant J., Painter R., Vessey M., Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study, Br J Obstet Gynaecol, 105, pp. 890-896, (1998)

[36]

Stampfer M.J., Willett W.C., Colditz G.A., Et al., A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases, N Engl J Med, 319, pp. 1313-1317, (1988)

[37]

Tanis B.C., van den Bosch M.A., Kemmeren J.M., Et al., Oral contraceptives and the risk of myocardial infarction, N Engl J Med, 345, pp. 1787-1793, (2001)

[38]

Jick H., Jick S., Myers M.W., Vasilakis C., Risk of acute myocardial infarction and low-dose combined oral contraceptives, Lancet, 347, pp. 627-628, (1996)

[39]

WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception, Lancet, 349, pp. 1202-1209, (1997)

[40]

Lewis M.A., Heinemann L.A., Spitzer W.O., Et al., The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women, Contraception, 56, pp. 129-140, (1997)

← 1 2 3 4 5 →